MedTechHub · Patient Care & Monitoring · Global

Hemodialysis Peritoneal Dialysis Market Size and Share - Growth Analysis Report and Forecast Trends 2026-2030

The global hemodialysis and peritoneal dialysis market represents the full ecosystem of equipment, consumables, and services used to treat patients with end-stage renal disease (ESRD) and severe chronic kidney disease (CKD) when their kidneys can no longer function adequately. Valued at approximately $110.6 billion in 2025, the market is projected to grow at a compound annual rate of roughly 6.6%, driven by rising CKD prevalence, aging populations, improved access to treatment infrastructure, and growing adoption of home-based dialysis modalities. North America currently represents the largest regional segment, though Asia-Pacific is expected to see the fastest expansion over the coming decade as healthcare systems in emerging economies scale up renal care capacity.

Market size · 2025
$111 billion
CAGR · 2025–2030
6.6%
Forecast · 2030
$152 billion
Basis
Claight Analysis
Market size (USD)
Base year 2025
Official data · Claight AnalysisForecast
Market size and forecast are Claight Analysis, informed by public research.
Forecast
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2025 base: $111bn2030 est: $152bn
Read the full Hemodialysis Peritoneal Dialysis Market report →

Market Overview

The hemodialysis and peritoneal dialysis market encompasses both in-center and home-based treatment solutions for patients with chronic kidney disease and end-stage renal disease. The market is broadly split into two primary treatment modalities, hemodialysis, which uses a machine to filter blood outside the body, and peritoneal dialysis, which leverages the patient's own abdominal membrane as a natural filter. Growth is fueled by increasing global incidence of kidney failure, rising prevalence of diabetes and hypertension as underlying conditions, and expanding insurance coverage for dialysis services across both developed and developing markets.

  • The global market was valued at approximately $110.6 billion in 2025, with projections placing it between $141 billion and $182 billion by the early 2030s depending on the forecast horizon.
  • Hemodialysis currently accounts for the larger share of treatments globally, though peritoneal dialysis and home-based hemodialysis are gaining share due to patient preference and cost advantages.

Growth Drivers

The primary engine of market expansion is the rising global burden of chronic kidney disease, which is increasingly linked to diabetes, obesity, hypertension, and an aging demographic profile. Expanding healthcare access in emerging markets, particularly in China, India, and Latin America, is opening large new patient populations that historically had limited dialysis availability. Technological advancements, including more compact and user-friendly home dialysis machines, wearable devices, and connected monitoring systems, are lowering barriers to home-based treatment and improving patient quality of life.

  • An estimated 2 million people globally receive renal replacement therapy each year, and this number continues to rise as CKD prevalence climbs.
  • Home-based dialysis adoption is accelerating due to reduced per-patient costs, improved clinical outcomes in some patient profiles, and policy incentives in markets such as the U.S. and Europe.
Want a deeper cut on Hemodialysis Peritoneal Dialysis Market? We build bespoke studies on request.
Connect to an analyst →

Segmentation and Regional Analysis

The market is segmented by type into hemodialysis and peritoneal dialysis, with hemodialysis further divided into in-center hemodialysis machines and home-based hemodialysis machines. Product-level segmentation covers devices (dialysis machines, dialyzers), consumables (blood tubing sets, dialysate solutions), and services. Geographically, North America, led by the United States, commands the largest share, while Europe holds the second-largest position. Asia-Pacific is the fastest-growing region, driven by rising disease incidence, government health investments, and improving healthcare infrastructure in countries such as China, India, and Southeast Asian nations.

  • The United States hemodialysis and peritoneal dialysis market alone is projected to exceed $67.5 billion by 2033, maintaining its position as the single largest national market.
  • Devices typically represent the largest revenue segment within the product category, followed by consumables and service contracts.

Trends and Outlook

What are the recent trends and outlook?

The most significant trend shaping the market is the accelerating shift toward home-based dialysis, supported by telehealth integration, portable machine designs, and policy frameworks that incentivize home treatment over facility-based care. Digital health tools, including remote patient monitoring and AI-driven treatment optimization, are increasingly embedded into dialysis workflows to improve adherence, reduce complications, and lower healthcare costs. The long-term outlook remains strongly positive, with the market expected to sustain mid-single-digit annual growth through the 2030s as CKD prevalence continues its upward trajectory and healthcare systems expand access to renal replacement therapies.

  • By the early 2030s, home-based dialysis could represent a significantly larger share of total treatment volume, particularly in markets where reimbursement policies support it.
  • Sustainability and product circularity are emerging considerations, with manufacturers exploring recycled dialysis consumables and eco-friendly manufacturing practices.
Talk to a Claight analyst
Do you want to research Hemodialysis Peritoneal Dialysis Market?

Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.

Connect to an analyst →

Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.